Side-to-side mesocaval shunt in portal hypertension.
Eighty-five consecutive patients underwent side-to-side mesocaval shunt with a success rate of 98.8% and a 30-day hospital mortality of 2.4%. Eighty cases were followed up for three months to eight years, eight died, encephalopathy occurred in three (4.3%), rebleeding in five, ascites in two and lower leg edema in three. A long history of hepatitis and impairment of liver function were the common features of dying patients. The rebleeding rate was 8.5%. Liver function had a significant influence on the outcome of treatment.
Chang
W H
WH
Department of Surgery, Third Hospital, Beijing Medical University, P.R. of China.
D000328:Adult; D004932:Esophageal and Gastric Varices / Q000209:etiology / Q000601:surgery; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000601:surgery; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical / Q000009:adverse effects / Q000379:methods* / Q000401:mortality